BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
1. Investigation launched into proposed sale of BLUE to Carlyle Group and SK Capital Partners. Deal terms include $3 per share cash plus contingent value rights. 2. Legal inquiry may affect final deal structure. Investigation details could influence market perception of BLUE.